IP Library › Assignment 062028/0479
Patent Assignment
Reel/Frame 062028/0479

Assignment of Assignor's Interest

Recorded: 2022-12-08 Pages: 7
Assignor
THERAPEUTICS, INC., CADENT
Executed: 2022-12-01
Assignee
NOVARTIS AG
LICHTSTRASSE 35, BASEL, 4056, SWITZERLAND
Covered Properties (6)
Thienopyrimidinone Nmda Receptor Modulators and Uses Thereof
Application: 16/060,294 →
Publication: US 2018/0369245
Thienopyrimidinone Nmda Receptor Modulators and Uses Thereof
Application: 16/658,686 →
Thienopyrimidinone Nmda Receptor Modulators and Uses Thereof
Application: 16/893,659 →
Thienopyrimidinone Nmda Receptor Modulators and Uses Thereof
Application: 17/150,222 →
Thienopyrimidinone Nmda Receptor Modulators and Uses Thereof
Application: 17/458,797 →
Publication: US 2022/0047600
Thienopyrimidinone Nmda Receptor Modulators and Uses Thereof
Application: 62/265,187 →
Related Assignments (3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 10, 2016
From: ANDERSON, DAVID R.; VOLKMANN, ROBERT A.; MENNITI, FRANK S.; FANGER, CHRISTOPHER
To: LUC THERAPEUTICS
Reel/Frame 037946/0375 →
Assignment of Assignor's Interest Mar 25, 2019
From: ANDERSON, DAVID R.; VOLKMANN, ROBERT A.; MENNITI, FRANK S.; FANGER, CHRISTOPHER
To: CADENT THERAPEUTICS, INC.
Reel/Frame 048689/0856 →
Assignment of Assignor's Interest Dec 2, 2021
From: ANDERSON, DAVID R.; VOLKMANN, ROBERT A.; MENNITI, FRANK S.; FANGER, CHRISTOPHER
To: CADENT THERAPEUTICS, INC.
Reel/Frame 058270/0306 →